We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 6,549 results
  1. Novel pathogenic variants in CUBN uncouple proteinuria from renal function

    Background

    Proteinuria is an unfavorable clinical condition highly associated with a risk of renal and cardiovascular disease in chronic kidney...

    Chun Gan, **ndi Zhou, ... Qiu Li in Journal of Translational Medicine
    Article Open access 20 October 2022
  2. Dogs with leishmaniosis: how are we managing proteinuria in daily practice? A Portuguese questionnaire-based study

    Background

    Proteinuria is a common finding in dogs with leishmaniosis. Although antileishmanial therapeutic protocols are widely implemented, little...

    Marta Monteiro, Sara Prata, ... Rodolfo Oliveira Leal in Parasites & Vectors
    Article Open access 11 April 2022
  3. Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

    Background

    Hypertension and proteinuria are common bevacizumab-induced toxicities. No validated biomarkers are available for identifying patients at...

    Julia C. F. Quintanilha, ** Wang, ... Federico Innocenti in British Journal of Cancer
    Article 06 October 2021
  4. Association between thyroid-stimulating hormone (TSH) and proteinuria in relation to thyroid cyst in a euthyroid general population

    Background

    High normal levels of thyroid-stimulating hormone (TSH) have been reported to be associated with chronic kidney disease (CKD) among...

    Yuji Shimizu, Yuko Nabeshima-Kimura, ... Naomi Hayashida in Journal of Physiological Anthropology
    Article Open access 09 October 2021
  5. Dipstick proteinuria and risk of type 2 diabetes mellitus: a nationwide population-based cohort study

    Background

    Proteinuria has been recognized as a marker of systemic inflammation and endothelial dysfunction associated with insulin resistance and...

    Jimin Jeon, **kwon Kim in Journal of Translational Medicine
    Article Open access 26 June 2021
  6. Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria

    Immune semaphorins are important in controlling both innate and adaptive immune responses. The regulatory role of semaphorin3A (sema3A) in systemic...

    Rimar Doron, Lidar Merav, ... Vadasz Zahava in Inflammation
    Article 25 September 2021
  7. Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats

    Background

    Trimethylamine oxide (TMAO) is a biomarker in cardiovascular and renal diseases. TMAO originates from the oxidation of trimethylamine...

    Klaudia M. Maksymiuk, Mateusz Szudzik, ... Marcin Ufnal in Journal of Translational Medicine
    Article Open access 15 October 2022
  8. Proteinuria as a presenting sign of combined methylmalonic acidemia and homocysteinemia: case report

    Background

    Disorders of the metabolism and absorption of vitamin B12 can lead to decrease in activity of methionine synthetase and methylmalonate...

    Ru-Yue Chen, **ao-Zhong Li, ... Xu-Qin Chen in BMC Medical Genetics
    Article Open access 21 September 2020
  9. Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

    A 24-h urine protein collection (24hUP), the gold standard for measuring albuminuria in systemic AL amyloidosis, is cumbersome and inaccurate. We...

    Alissa Visram, Abdullah S. Al Saleh, ... Nelson Leung in Blood Cancer Journal
    Article Open access 11 December 2020
  10. Severe proteinuria during the administration of bevacizumab plus mFOLFOX6 in a colorectal cancer patient after kidney transplantation: a case report

    Background

    Bevacizumab (BEV) leads to proteinuria and renal damage. It is not clear whether the administration of immunosuppressive drugs after renal...

    Ren Onodera, Satoru Nihei, ... Kenzo Kudo in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 04 September 2020
  11. Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study

    Background

    To date, the association of serum macrophage migration inhibitory factor (MIF) and serum adipokines with lupus nephritis is controversial.

    ...
    Jorge Ivan Gamez-Nava, Valeria Diaz-Rizo, ... Laura Gonzalez-Lopez in Biomarker Research
    Article Open access 28 October 2020
  12. Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumab

    Belimumab was approved for active lupus nephritis (LN) in adults in the European Union and patients ≥ 5 years of age in the USA based on a Phase 3,...

    Monica Simeoni, Shuying Yang, ... Richard Dimelow in Journal of Pharmacokinetics and Pharmacodynamics
    Article Open access 29 March 2024
  13. Role of Renin Angiotensin-Aldosterone System in Kidney Homeostasis

    The Renin-Angiotensin-Aldosterone System (RAAS), which regulates plasma sodium levels, arterial blood pressure, and extracellular volume, is a...
    Ravi Kant, Sneha Gupta, ... Nirmal Kumar Ganguly in The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases
    Chapter 2023
  14. Protopanaxadiol improves lupus nephritis by regulating the PTX3/MAPK/ERK1/2 pathway

    Lupus nephritis (LN) is a kidney disease that occurs after systemic lupus erythematosus (SLE) affects the kidneys. Pentraxin 3 (PTX3) is highly...

    Zhenyuan Li, Hailin Gan, ... Huaying Fan in Journal of Natural Medicines
    Article 03 March 2024
  15. A deletion variant in LMX1B causing nail–patella syndrome in Japanese twins

    Nail–patella syndrome (NPS) is a hereditary disease caused by pathogenic variants in LMX1B and characterized by nail, limb, and renal symptoms. This...

    Nozomu Kishio, Kazuhiro Iwama, ... Shuichi Ito in Human Genome Variation
    Article Open access 29 February 2024
  16. Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype

    Background

    The clinical heterogeneity of SLE with its complex pathogenesis remains challenging as we strive to provide optimal management. The...

    MacIntosh G. Cornwell, Hanane El Bannoudi, ... Jeffrey S. Berger in Journal of Translational Medicine
    Article Open access 07 April 2023
  17. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway

    Sirtuins (Sirts) are a family of nicotinamide adenine dinucleotide-dependent protein deacetylases that share diverse cellular functions. Increasing...

    Hua Miao, Yan-ni Wang, ... Ying-yong Zhao in Acta Pharmacologica Sinica
    Article 28 August 2023
  18. A novel COL4A5 splicing mutation causes alport syndrome in a Chinese family

    Background

    Alport syndrome (AS) is characterised by haematuria, proteinuria, a gradual decline in kidney function, hearing loss, and eye...

    Suyun Chen, Guangbiao Xu, ... Chun** Li in BMC Medical Genomics
    Article Open access 26 April 2024
  19. Suitability of reduced dose glucocorticoids therapy regimen for antibody-associated vasculitis patients with TB: a retrospective study

    Intention

    Immunosuppressive therapy is the major treatment approach for patients with anti-neutrophil cytoplasmic antibody-associated vasculitis...

    Article 27 March 2024
Did you find what you were looking for? Share feedback.